BENTONVILLE, Arkansas, March 23, 2023 -- McapMediaWire -- Glucose Health, Inc. (OTC: GLUC) ("Company") is pleased to highlight selected financial metrics presented in its Annual Report posted today at OTCMarkets.com. For fiscal 2022, Glucose Health, Inc. surpassed $1m in annual revenues for the first time in its history.  Additionally, despite intense ingredient, packaging and transportation cost pressures, the Company managed to increase its gross profits commensurate with its...

BENTONVILLE, AR, October 24, 2022 -- McapMediaWire -- Glucose Health, Inc. (OTC Pink: GLUC) ("Company") confirms the following important corporate developments. Three outstanding candidates have now accepted nominations to serve as independent directors of the Company. Charters for the enactment of Audit, Compensation and Corporate Governance/Nominations committees, each comprised, or majority comprised, of the independent directors, have been established. The Company appointed a Public...

BENTONVILLE, AR, October 24, 2022 -- McapMediaWire -- Glucose Health, Inc. (OTC Pink: GLUC) ("Company") is pleased to highlight selected financial information from its third Quarterly Report of Fiscal 2022, for the period ended September 30, 2022, posted today at OTCMarkets.com. Q3 2022 Revenue of $340,681 vs. $234,930 for Q3 2021 = a 45% increase. Q3 2022 Gross Profit of $153,789 vs. $62,032 for Q3 2021 = a 148% increase. Q3 2022 Net Income of $8,091 vs. Q3 2021 Net...

BENTONVILLE, AR, March 17, 2022 -- McapMediaWire -- Glucose Health, Inc. (OTC Pink: GLUC) ("Company") announced today, it has accepted the resignations of Hal Kravitz and John Fieldly from the Company's board of directors. About Glucose Health, Inc. Manufactured by Glucose Health, Inc., the GLUCODOWN® brand is defining a new beverage industry category – functional, diabetic friendly, beverages. By specializing in producing healthy and delicious beverages, nutritionally appropriate1 for the...

BENTONVILLE, AR, Feb. 10, 2022 -- McapMediaWire -- Glucose Health, Inc. (OTC: GLUC) ("Company") is pleased to highlight selected financial metrics presented in its Fiscal 2021 Annual Report posted today at OTCMarkets.com. In fiscal 2021, Glucose Health, Inc. more than doubled gross profits, effectively doubled revenue, and achieved the unique status of a debt free, emerging growth, company. Fiscal 2021 Revenue of $953,681 vs. $480,713 for Fiscal 2020 = a 98% increase. Fiscal 2021 Gross Profit...